Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
Nicolas Lepareur(Inserm), F. F. Knapp(Oak Ridge National Laboratory)
Cited by 154
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Rhenium-188: Availability from the 188W/188Re Generator and Status of Current Applications
|Current Radiopharmaceuticals|2012|94
99Mo/99mTc separation: An assessment of technology options
|Nuclear Medicine and Biology|2012|88